Oruka Therapeutics, Inc.

NASDAQ:ORKA

Biotechnology

Healthcare
$95.74 +0.65%

+$0.46 today

Market cap
$6.49B
Beta
-0.30
P/E (TTM)
-33.9
EPS (TTM)
-$2.11
52W Low $10.77High $91.00

Volume 0.52M

Average 1.55M

ORKA Interest Income

Income earned on cash, deposits, and investments held by the company.

Oruka Therapeutics, Inc.NASDAQ: ORKA

Interest Income · Q3 FY2026 · quarter ended Sep 2026

Interest income growth accelerates

Q3 FY2026 interest income of $12.17M rose 217.5% year over year, ahead of the +87.1% change in trailing-twelve-month interest income. Sequentially, it rose 36.7% from the prior quarter. Over 3 fiscal years it compounded at +191.0% a year.

Context

  • Interest income increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +217.5% holds above the trailing-twelve-month pace of +87.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$12.17M+36.7% QoQ
Last fiscal yearDec 2025
$16.63M+183.6% YoY
LTMSep 2026
$30.52M+87.1% YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+217.5%——
1 year+183.6%——
3-year CAGR+191.0%——
5-year CAGR——
10-year CAGR——

Interest Income history

USD · from the income statement

Latest · FY2025
16.63M USD
Year-over-year change
+183.6%

Interest Income vs competitors

How ORKA compares with its peers on the latest reported figures

  • ORKA's LTM Sep 2026 interest income of $30.52M is the highest of the 10 companies compared; the peer median is $6.99M.
  • Its year-over-year change of +87.1% is the 2nd highest of 9, against a peer median of -19.3%.
  • Over three fiscal years its annual growth of +191.0% compares with a peer median of +85.6%.
ORKA Competitors Peer median
Interest Income for ORKA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ORKAOruka Therapeutics, Inc.LTM Sep 2026$30.52M +87.1%+191.0%—
DNTHDianthus Therapeutics, Inc.LTM Jun 2026$26.73M +71.0%+141.5%1404.0%
XNCRXencor, Inc.LTM Jun 2026$23M -24.6%+78.8%21.9%
ALMSAlumis Inc. Common StockLTM Jun 2026$18.44M +21.1%+92.4%249.2%
ANABAnaptysBio, Inc.LTM Mar 2026$11.74M -40.2%+21.4%5.1%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$6.99M -14.1%—83.5%
ATTOAttovia Therapeutics, Inc.FY2025$6.63M +92.8%—490.9%
ZURAZura Bio LimitedLTM Mar 2026$5.84M -32.1%+2131.8%—
CNTBConnect Biopharma Holdings LimitedFY2025$2.27M -49.1%+13.2%3543.8%
MLTXMoonLake ImmunotherapeuticsLTM Mar 2026$0 ———
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding ORKA) $6.99M-19.3%+85.6%249.2%

Competitors are the stored peer set for ORKA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue91K114K111K27K83K
Gross Profit(91K)(114K)(111K)(27K)(83K)
Gross Margin—————
Research & Development13.83M4.46M1.01M75.06M100.64M
Selling, General & Admin5.41M5.26M6.17M13.04M21.33M
Operating Expenses19.24M9.73M7.19M88.1M121.97M
Depreciation & Amortization91K114K111K27K83K
EBITDA(19.23M)(9.81M)(5.23M)(82.23M)(105.35M)
EBITDA Margin—————
Operating Income(19.34M)(9.84M)(7.3M)(88.12M)(122.05M)
Operating Margin—————
Interest Income0675K1.96M5.86M16.63M
Interest Expense0001.47M0
Other Income / Expenses13K(85K)1.96M4.4M16.62M
Income Before Tax(19.32M)(9.93M)(5.34M)(83.72M)(105.43M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(19.32M)(9.93M)(5.34M)(83.72M)(105.43M)
Net Margin—————
EPS (Basic)(16.68)(8.27)(4.44)(4.99)(2.31)
EPS (Diluted)(16.68)(8.27)(4.44)(4.99)(2.31)
Weighted Avg Shares13.9M14.41M14.42M16.79M45.61M
Weighted Avg Shares (Diluted)13.9M14.41M14.42M16.79M45.61M

Oruka Therapeutics, Inc.

NASDAQ:ORKA

Intrinsic Alpha fair value

Locked

Current Price

$95.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.